These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 35246429)

  • 1. Nephrotic syndrome with minimal change disease after the Pfizer-BioNTech COVID-19 vaccine: two cases.
    Hartley JL; Bailey N; Sharma A; Shawki H
    BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35246429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric Minimal Change Disease and AKI following the Pfizer-BioNTech COVID-19 Vaccine: causal or incidental correlation?
    Annicchiarico Petruzzelli L; Minale B; Serio V; De Luca A; Marino Marsilia G; Campione S; Diomedi Camassei F; D'Arcangelo R; Luongo I; Lepore L; Giannattasio P; Molino D; Pirro L; Lonardo MC; Malgieri G; Pecoraro C
    G Ital Nefrol; 2022 Dec; 39(6):. PubMed ID: 36655832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Lebedev L; Sapojnikov M; Wechsler A; Varadi-Levi R; Zamir D; Tobar A; Levin-Iaina N; Fytlovich S; Yagil Y
    Am J Kidney Dis; 2021 Jul; 78(1):142-145. PubMed ID: 33839200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minimal change disease and acute kidney injury following the Pfizer-BioNTech COVID-19 vaccine.
    D'Agati VD; Kudose S; Bomback AS; Adamidis A; Tartini A
    Kidney Int; 2021 Aug; 100(2):461-463. PubMed ID: 34000278
    [No Abstract]   [Full Text] [Related]  

  • 5. New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review.
    Nakazawa E; Uchimura T; Hirai Y; Togashi H; Oyama Y; Inaba A; Shiga K; Ito S
    CEN Case Rep; 2022 May; 11(2):242-246. PubMed ID: 34782983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De Novo Minimal Change Disease following Vaccination with the Pfizer/BioNTech SARS-CoV-2 Vaccine in a Living Kidney Donor.
    Marinaki S; Kolovou K; Liapis G; Skalioti C; Tsiakas S; Boletis I
    Medicina (Kaunas); 2021 Dec; 58(1):. PubMed ID: 35056345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of Minimal Change Disease Following mRNA COVID-19 Vaccination.
    Pirzadeh A; Emami S; Zuckerman JE; Nobakht N
    Am J Case Rep; 2023 Nov; 24():e941621. PubMed ID: 37941318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.
    Meo SA; Bukhari IA; Akram J; Meo AS; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Feb; 25(3):1663-1669. PubMed ID: 33629336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal change disease following the Moderna COVID-19 vaccine: first case report.
    Thappy S; Thalappil SR; Abbarh S; Al-Mashdali A; Akhtar M; Alkadi MM
    BMC Nephrol; 2021 Nov; 22(1):376. PubMed ID: 34763669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review.
    Lim JH; Han MH; Kim YJ; Kim MS; Jung HY; Choi JY; Cho JH; Kim CD; Kim YL; Park SH
    J Korean Med Sci; 2021 Aug; 36(30):e218. PubMed ID: 34342187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.
    Meo SA; Fahad Al-Jassir F; Al-Qahtani S; Albarrak R; Usmani AM; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7185-7191. PubMed ID: 34859883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Additional Case of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Maas RJ; Gianotten S; van der Meijden WAG
    Am J Kidney Dis; 2021 Aug; 78(2):312. PubMed ID: 33992727
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapse of Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
    Komaba H; Wada T; Fukagawa M
    Am J Kidney Dis; 2021 Sep; 78(3):469-470. PubMed ID: 34023417
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative Effectiveness and Antibody Responses to Moderna and Pfizer-BioNTech COVID-19 Vaccines among Hospitalized Veterans - Five Veterans Affairs Medical Centers, United States, February 1-September 30, 2021.
    Bajema KL; Dahl RM; Evener SL; Prill MM; Rodriguez-Barradas MC; Marconi VC; Beenhouwer DO; Holodniy M; Lucero-Obusan C; Brown ST; Tremarelli M; Epperson M; Mills L; Park SH; Rivera-Dominguez G; Morones RG; Ahmadi-Izadi G; Deovic R; Mendoza C; Jeong C; Schrag SJ; Meites E; Hall AJ; Kobayashi M; McMorrow M; Verani JR; Thornburg NJ; Surie D; ; ;
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(49):1700-1705. PubMed ID: 34882654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune-mediated thrombotic thrombocytopenic purpura following administration of Pfizer-BioNTech COVID-19 vaccine.
    Giuffrida G; Condorelli A; Di Giorgio MA; Markovic U; Sciortino R; Nicolosi D; Di Raimondo F
    Haematologica; 2022 Apr; 107(4):1008-1010. PubMed ID: 34382388
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimal Change Disease With Severe Acute Kidney Injury Following the Oxford-AstraZeneca COVID-19 Vaccine: A Case Report.
    Leclerc S; Royal V; Lamarche C; Laurin LP
    Am J Kidney Dis; 2021 Oct; 78(4):607-610. PubMed ID: 34242687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Report of two cases of minimal change disease following vaccination for COVID -19.
    Baskaran K; Cohen AWS; Weerasinghe N; Vilayur E
    Nephrology (Carlton); 2022 Jan; 27(1):111-112. PubMed ID: 34779088
    [No Abstract]   [Full Text] [Related]  

  • 18. Surveillance for Multisystem Inflammatory Syndrome in US Children Aged 5-11 Years Who Received Pfizer-BioNTech COVID-19 Vaccine, November 2021 through March 2022.
    Cortese MM; Taylor AW; Akinbami LJ; Thames-Allen A; Yousaf AR; Campbell AP; Maloney SA; Harrington TA; Anyalechi EG; Munshi D; Kamidani S; Curtis CR; McCormick DW; Staat MA; Edwards KM; Creech CB; Museru O; Marquez P; Thompson D; Su JR; Schlaudecker EP; Broder KR
    J Infect Dis; 2023 Jul; 228(2):143-148. PubMed ID: 36821777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pityriasis lichenoides chronica after BNT162b2 Pfizer-BioNTech vaccine: A novel cutaneous reaction after SARS-CoV-2 vaccine.
    Drago F; Ciccarese G; Guadagno A; Parodi A
    J Eur Acad Dermatol Venereol; 2022 Dec; 36(12):e979-e981. PubMed ID: 35841285
    [No Abstract]   [Full Text] [Related]  

  • 20. Minimal change disease and acute interstitial nephritis following SARS-CoV-2 BNT162b2 vaccination.
    Jongvilaikasem P; Rianthavorn P
    Pediatr Nephrol; 2022 Jun; 37(6):1419-1421. PubMed ID: 35132446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.